Legal & General Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,381
| Closed | -$7K | – | 3730 |
|
|
2022
Q1 | $7K | Hold |
2,381
| – | – | ﹤0.01% | 3477 |
|
|
2021
Q4 | $11K | Sell |
2,381
-6,054
| -72% | -$28K | ﹤0.01% | 3450 |
|
|
2021
Q3 | $72K | Buy |
8,435
+4,883
| +137% | +$41.7K | ﹤0.01% | 2904 |
|
|
2021
Q2 | $58K | Sell |
3,552
-42
| -1% | -$686 | ﹤0.01% | 2909 |
|
|
2021
Q1 | $80K | Buy |
3,594
+209
| +6% | +$4.65K | ﹤0.01% | 2679 |
|
|
2020
Q4 | $104K | Buy |
3,385
+1,171
| +53% | +$36K | ﹤0.01% | 2582 |
|
|
2020
Q3 | $45K | Buy |
2,214
+104
| +5% | +$2.11K | ﹤0.01% | 2736 |
|
|
2020
Q2 | $32K | Buy |
2,110
+538
| +34% | +$8.16K | ﹤0.01% | 2870 |
|
|
2020
Q1 | $10K | Sell |
1,572
-426
| -21% | -$2.71K | ﹤0.01% | 3168 |
|
|
2019
Q4 | $29K | Buy |
1,998
+42
| +2% | +$610 | ﹤0.01% | 3067 |
|
|
2019
Q3 | $29K | Buy |
1,956
+1,411
| +259% | +$20.9K | ﹤0.01% | 2987 |
|
|
2019
Q2 | $8K | Buy |
+545
| New | +$8K | ﹤0.01% | 3404 |
|